BioDlink International Company Limited (BioDlink) filed its monthly return for the period ended 31 July 2026, confirming no movements in either issued or treasury shares. The number of ordinary shares in issue stayed at 772.79 million, with zero treasury shares on the balance sheet.

The company reconfirmed compliance with Hong Kong’s 25 percent minimum public-float requirement.

Under the Pre-IPO Share Option Scheme adopted on 20 February 2013, 0.02 million options were outstanding at month-end, unchanged from the previous month, and no options were granted, exercised, cancelled or lapsed. The options, if fully exercised, would expand the share base by only 0.00 percent.

No warrants, convertibles, or other share-issuance arrangements were outstanding, and no proceeds were raised during the month.